Physician profile
Gerald Salinas
NPI 1821061136
$2,879.81
in general payments reported to CMS, 2019-2025
34 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554 · 2020: $158 · 2021: $318 · 2022: $470 · 2023: $508 · 2024: $507 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $363.84 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $343.70 | 2019-2025 | |
| Abbvie INC. | $241.28 | 2022-2025 | Ubrelvy, Qulipta |
| Lilly USA, LLC | $185.27 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $132.53 | 2019-2025 | Farxiga, Breztri |
| Amarin Pharma, INC. | $118.63 | 2019-2021 | |
| Glaxosmithkline, LLC. | $115.66 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Amgen INC. | $101.81 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $99.28 | 2019-2023 | Vaxelis, Gardasil 9, M-M-R II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.21 | 2019-2025 | Jardiance |
| Dexcom, INC. | $86.28 | 2021-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $84.79 | 2021 | |
| Exact Sciences Corporation | $84.26 | 2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $79.82 | 2019-2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.99 | 2021-2024 | Xifaxan |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $72.97 | 2022 | |
| Allergan, INC. | $71.86 | 2019-2020 | |
| Corium, LLC | $66.88 | 2023-2024 | Azstarys |
| E.R. Squibb & Sons, L.L.C. | $62.76 | 2020-2024 | Eliquis |
| Takeda Pharmaceuticals U.S.A., INC. | $53.47 | 2019-2023 | Trintellix |
| Abbott Laboratories | $49.53 | 2022-2023 | Freestyle Libre 3 |
| Ironshore Pharmaceuticals INC. | $41.39 | 2022-2023 | Jornay Pm |
| Eisai INC. | $38.07 | 2021-2025 | |
| Genentech USA, INC. | $35.00 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $29.79 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $19.83 | 2022 | |
| Esperion Therapeutics, INC. | $19.01 | 2021 | |
| Dynavax Technologies Corporation | $18.07 | 2025 | Heplisav-B |
| Novartis Pharmaceuticals Corporation | $16.93 | 2021 | |
| Shield Therapeutics INC | $16.78 | 2025 | |
| Sanofi Pasteur INC. | $15.30 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $15.20 | 2022 | |
| Clarus Therapeutics INC. | $14.87 | 2021 | |
| Shire North American Group INC | $14.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Salinas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.